SmiLe Incubator

Call Knut is the developer of communication software designed to check in the elderly.

TIGERQ is a sample-to-analysis gene editing solution that combines proprietary sequencing algorithms with cost-effective and rapid turnaround sample processing services. The company works with commercializing services related to the Nobel-prize awarded CRISPR-Cas9 method.

Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.

In2cure is a company that exploits new scientific discoveries on natural host defenses for novel therapies.

Thyrolytics develops a first-of-its-kind diagnostic device for measuring serum levels of free T4 and T3.

ReceptorPharma is a drug discovery company utilizing a completely new pathway to treat Alzheimer’s disease.

Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.

SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits. The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.

Medotemic develops solutions for objective gait deviation analysis, e.g. resulting from injury or pain. Sensor data collected via the smartphone alone is analyzed via proprietary algorithms.

POOW Applications has developed The Food Hero app that helps children with different types of eating disorders.

Medow develops innovative health care products that bring efficiency, comfort and joy by using design and colour.

Truly Labs provides tailor-made in vitro and in vivo services.

Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as well as providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.

Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins.

Speximo develops an emulsifier based on starch grain from quinoa. Applications are in the cosmetics, pharmaceutical and food industries. With Speximo's technology you can produce creams and ointments with a completely green profile. Speximo AB is a research based company providing competence and a patented emulsifying technology for oil-water based products. The lab continuously solves formulation problems and explores new applications. Since 2013 the headquarter and R&D facilities are placed at Medicon Village in Lund, Sweden. Speximo offers green and sustainable stabilization of emulsions. The technology provides opportunities ranging from stabilization of surfactant free systems to encapsulation of high value ingredients. Speximo was founded by the world leading experts in starch Pickering emulsions and has close collaboration with researchers from Lund University and Malmö University exploring the fundamental properties of the technology and its use in cosmetic, pharmaceutical, and food applications.

SARomics Biostructures sells services and projects against pharmaceutical companies. Information on how drug substance and target molecule interact with each other is essential in order to quickly and efficiently develop new drugs.